NDC 49702-217

TRIZIVIR

Abacavir Sulfate, Lamivudine, And Zidovudine

TRIZIVIR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Abacavir Sulfate; Lamivudine; Zidovudine.

• Product ID: 49702-217_1001c7d9-56da-44f8-ba9c-a45be7a239b7
• NDC: 49702-217
• Product Type: Human Prescription Drug
• Proprietary Name: TRIZIVIR
• Generic Name: Abacavir Sulfate, Lamivudine, And Zidovudine
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2010-11-02
• Marketing Category: NDA / NDA
• Application Number: NDA021205
• Labeler Name: ViiV Healthcare Company
• Substance Name: ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
• Active Ingredient Strength: 300 mg/1; mg/1; mg/1
• Pharm Classes: Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 49702-217-18

60 TABLET, FILM COATED in 1 BOTTLE (49702-217-18)

• Marketing Start Date: 2010-11-02
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49702-217-18 [49702021718]

TRIZIVIR TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA021205
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-11-02

Drug Details

Active Ingredients

Ingredient	Strength
ABACAVIR SULFATE	300 mg/1

OpenFDA Data

• SPL SET ID: 9b32f5a4-d0f7-486b-b699-8dc9202b6869
• Manufacturer:
  • ViiV Healthcare Company
• UNII:
  • J220T4J9Q2
  • 2T8Q726O95
  • 4B9XT59T7S
• RxNorm Concept Unique ID - RxCUI:
  • 285028
  • 307650

Pharmacological Class

• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]

Medicade Reported Pricing

49702021718 TRIZIVIR TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "TRIZIVIR" or generic name "Abacavir Sulfate, Lamivudine, And Zidovudine"

NDC	Brand Name	Generic Name
49702-217	TRIZIVIR	abacavir sulfate, lamivudine, and zidovudine
53808-0990	TRIZIVIR	abacavir sulfate, lamivudine, and zidovudine